Gayot, Caroline
Laubarie-Mouret, Cécile
Zarca, Kevin
Mimouni, Maroua
Cardinaud, Noelle
Luce, Sandrine
Tovena, Isabelle
Durand-Zaleski, Isabelle
Laroche, Marie-Laure
Preux, Pierre-Marie
Tchalla, Achille
Article History
Received: 8 June 2022
Accepted: 1 November 2022
First Online: 22 December 2022
Declarations
:
: The trial received ethical approval from the local institutional review board (Comité de Protection des Personnes du Sud-ouest et Outre-mer IV) on the 15<sup>th</sup> of July, 2015. The French « <i>Agence Nationale de Sécurité du Médicament et des Produits de Santé</i>» was notified on the 16<sup>th</sup> of September, 2015. The trial was registered with ClinicalTrials.gov on the 28<sup>th</sup> of June, 2016 (NCT02816177). Patients or their legal representatives gave written informed consent. We confirm that all experiments were performed in accordance with relevant guidelines and regulations.
: Not applicable.
: No author has any competing interest.